Pure Global

Clinical Trial - Trial KCT0007269

Access comprehensive clinical trial information for KCT0007269 through Pure Global AI's free database. This Phase 2 trial is sponsored by Kyungpook National University Medical Center and is currently Not yet recruiting. The study focuses on Gastric cancer.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Korean Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
KCT0007269
Phase 2
Not yet recruiting
Trial Details
Korean Clinical Trial Registry โ€ข KCT0007269
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Untitled Trial
Phase II Study of Azacitidine Plus Oxaliplatin in Subjects with Recurrent and Metastatic Epstein-Barr virus-associated Gastric cancer

Study Focus

Gastric cancer

Interventional

Sponsor & Location

Kyungpook National University Medical Center

Boryung Pharm

South Korea

Timeline & Enrollment

Phase 2

N/A

N/A

ICD-10 Classifications

Gastric ulcer
Malignant neoplasm of stomach
Malignant neoplasm: Body of stomach
Carcinoma in situ: Stomach
Malignant neoplasm: Stomach, unspecified

Data Source

Korean Clinical Trial Registry

KCT0007269

Non-Device Trial